S'abonner

Population-level surveillance of congenital heart defects among adolescents and adults in Colorado: Implications of record linkage - 16/08/20

Doi : 10.1016/j.ahj.2020.04.008 
Tessa L. Crume, PhD, MSPH a, , Lindsey M. Duca, PhD, MS a, Toan Ong, PhD b, Emily Kraus, PhD, MPH c, Ken Scott, PhD, MPH c, Amber Khanna, MD, MS d, David Kao, MD, MS d, Christopher M. Rausch, MD e, Lisa McKenzie, PhD, MPH f, Matthew F. Daley, MD g, Suzanne Coleman, PhD, DHSc h, Michael G. Kahn, MD, PhD b, Everett Costa, DM i, Arthur J. Davidson, MD, MSPH c
a University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Department of Epidemiology, Aurora, CO 
b University of Colorado Anschutz Medical Campus, Colorado School of Medicine, Department of Pediatrics, Aurora, CO 
c Denver Health and Hospital Authority, Denver Public Health, Denver, CO 
d University of Colorado Anschutz Medical Campus, Colorado School of Medicine, Division of Cardiology, Departments of Internal Medicine and Pediatrics, Aurora, CO 
e Children's Hospital of Colorado, Department of Cardiology, Aurora, CO 
f University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Department of Environmental and Occupational Health, Aurora, CO 
g Institute of Health Research, Kaiser Permanente Colorado, Aurora, CO 
h Centura Health, Research Operations, Centennial, CO 
i Center for Improving Value in Healthcare, Denver, CO 

Reprint requests: Tessa Crume, PhD, MSPH, Associate Professor, Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, 13001 E 17th Ave, Box B119, Room W3137, Aurora, CO 80045.Department of Epidemiology, Colorado School of Public HealthUniversity of Colorado Anschutz Medical Campus13001 E 17th Ave, Box B119, Room W3137AuroraCO80045

Abstract

Background

The objective was to describe the design of a population-level electronic health record (EHR) and insurance claims-based surveillance system of adolescents and adults with congenital heart defects (CHDs) in Colorado and to evaluate the bias introduced by duplicate cases across data sources.

Methods

The Colorado CHD Surveillance System ascertained individuals aged 11-64 years with a CHD based on International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic coding between 2011 and 2013 from a diverse network of health care systems and an All Payer Claims Database (APCD). A probability-based identity reconciliation algorithm identified duplicate cases. Logistic regression was conducted to investigate bias introduced by duplicate cases on the relationship between CHD severity (severe compared to moderate/mild) and adverse outcomes including all-cause mortality, inpatient hospitalization, and major adverse cardiac events (myocardial infarction, congestive heart failure, or cerebrovascular event). Sensitivity analyses were conducted to investigate bias introduced by the sole use or exclusion of APCD data.

Results

A total of 12,293 unique cases were identified, of which 3,476 had a within or between data source duplicate. Duplicate cases were more likely to be in the youngest age group and have private health insurance, a severe heart defect, a CHD comorbidity, and higher health care utilization. We found that failure to resolve duplicate cases between data sources would inflate the relationship between CHD severity and both morbidity and mortality outcomes by ~15%. Sensitivity analyses indicate that scenarios in which APCD was excluded from case finding or relied upon as the sole source of case finding would also result in an overestimation of the relationship between a CHD severity and major adverse outcomes.

Discussion

Aggregated EHR- and claims-based surveillance systems of adolescents and adults with CHD that fail to account for duplicate records will introduce considerable bias into research findings.

Conclusion

Population-level surveillance systems for rare chronic conditions, such as congenital heart disease, based on aggregation of EHR and claims data require sophisticated identity reconciliation methods to prevent bias introduced by duplicate cases.

Le texte complet de cet article est disponible en PDF.

Plan


© 2020  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 226

P. 75-84 - août 2020 Retour au numéro
Article précédent Article précédent
  • Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations
  • Nancy Luo, Bradley G. Hammill, Adam D. DeVore, Haolin Xu, Gregg C. Fonarow, Nancy M. Albert, Roland A. Matsouaka, Adrian F. Hernandez, Clyde Yancy, Robert J. Mentz
| Article suivant Article suivant
  • Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
  • Larry R. Jackson, Sunghee Kim, Rosalia Blanco, Laine Thomas, Jack Ansell, Gregg C. Fonarow, Bernard J. Gersh, Alan S. Go, Peter R. Kowey, Kenneth W. Mahaffey, Elaine M. Hylek, Eric D. Peterson, Jonathan P. Piccini, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.